Valuation dashboard for Teleflex Incorporated (TFX) with P/E N/A, P/B 1.86, EV/EBITDA -33.89 and dividend yield 1.10%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide.
Analysis Summary
Teleflex Incorporated reported revenue of $1.99B in the most recent fiscal year, growing at a 5-year CAGR of -4.7%.
Trailing-twelve-month margins: gross margin 53.8%, operating margin 3.3%, net margin -39.6%.
At the current price of $124.12, TFX has negative trailing earnings (P/E not meaningful) and an ROE of -31.83%. Market capitalisation stands at $5.5B.
Balance sheet quality for TFX: current ratio of 2.5. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.86 |
| EV / EBITDA | -33.89 |
| Dividend Yield | 1.10% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| TFX | Teleflex Incorporated | $5.5B | 1.86 | -31.8% | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $9.1B | 19.36 | -60.5% | |
| PCVX | Vaxcyte, Inc. | $8.2B | 2.96 | -37.6% | |
| KRYS | Krystal Biotech, Inc. | $9.6B | 38.97 | 7.00 | 16.8% |
| PTCT | PTC Therapeutics, Inc. | $5.4B | 8.85 | -332.5% | |
| ALKS | Alkermes plc | $6.7B | 106.10 | 3.94 | 3.7% |
| CRSP | CRISPR Therapeutics AG | $5.3B | 3.06 | -30.3% | |
| MMSI | Merit Medical Systems, Inc. | $5.1B | 40.62 | 3.29 | 8.1% |
Price
| Price | $124.12 |
| Market Cap | $5.5B |
| Exchange | NYSE |
| Country | US |
Profitability
| Return on Equity | -31.83% |
| Return on Invested Capital | 1.30% |
| Return on Assets | -15.17% |
| Gross Margin | 53.77% |
| Operating Margin | 3.35% |
| Net Margin | -39.58% |
Related companies: ALKS · ARWR · BLCO · CRSP · KRYS · MMSI · PCVX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of TFX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks